Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition
- PMID: 30481275
- PMCID: PMC6357796
- DOI: 10.1093/aje/kwy259
Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition
Abstract
The role of hormonal factors in the etiology of lymphoid neoplasms remains unclear. Previous studies have yielded conflicting results, have lacked sufficient statistical power to assess many lymphoma subtypes, or have lacked detailed information on relevant exposures. Within the European Prospective Investigation Into Cancer and Nutrition cohort, we analyzed comprehensive data on reproductive factors and exogenous hormone use collected at baseline (1992-2000) among 343,458 women, including data on 1,427 incident cases of B-cell non-Hodgkin lymphoma (NHL) and its major subtypes identified after a mean follow-up period of 14 years (through 2015). We estimated hazard ratios and 95% confidence intervals using multivariable proportional hazards modeling. Overall, we observed no statistically significant associations between parity, age at first birth, breastfeeding, oral contraceptive use, or ever use of postmenopausal hormone therapy and risk of B-cell NHL or its subtypes. Women who had undergone surgical menopause had a 51% higher risk of B-cell NHL (based on 67 cases) than women with natural menopause (hazard ratio = 1.51, 95% confidence interval: 1.17, 1.94). Given that this result may have been due to chance, our results provide little support for the hypothesis that sex hormones play a role in lymphomagenesis.
Similar articles
-
Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort.Int J Cancer. 2009 Jun 1;124(11):2737-43. doi: 10.1002/ijc.24248. Int J Cancer. 2009. PMID: 19253366 Free PMC article.
-
Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women.Cancer Causes Control. 2012 Dec;23(12):2031-40. doi: 10.1007/s10552-012-0084-x. Epub 2012 Oct 23. Cancer Causes Control. 2012. PMID: 23090034
-
Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.Int J Cancer. 2011 Aug 15;129(4):974-82. doi: 10.1002/ijc.25730. Epub 2010 Dec 8. Int J Cancer. 2011. PMID: 20957632 Free PMC article.
-
Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis.Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):20-38. doi: 10.1158/1055-9965.EPI-11-0834. Epub 2011 Oct 25. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22028402 Free PMC article. Review.
-
The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.Front Oncol. 2018 Apr 16;8:103. doi: 10.3389/fonc.2018.00103. eCollection 2018. Front Oncol. 2018. PMID: 29713614 Free PMC article. Review.
Cited by
-
Increased Risk of Lymphoma in Men or the Elderly Infected with Tuberculosis.Mediterr J Hematol Infect Dis. 2021 Sep 1;13(1):e2021053. doi: 10.4084/MJHID.2021.053. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34527205 Free PMC article.
-
Secular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017.J Cancer. 2021 Feb 22;12(8):2326-2335. doi: 10.7150/jca.52186. eCollection 2021. J Cancer. 2021. PMID: 33758609 Free PMC article.
-
Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma.Int J Cancer. 2024 Apr 15;154(8):1433-1442. doi: 10.1002/ijc.34820. Epub 2023 Dec 19. Int J Cancer. 2024. PMID: 38112671 Free PMC article.
-
Fertility treatment and risk of non-Hodgkin lymphoma - results from a Danish population-based cohort study.Cancer Causes Control. 2025 Jun 2. doi: 10.1007/s10552-025-02017-z. Online ahead of print. Cancer Causes Control. 2025. PMID: 40456964
-
Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper.BMJ Open. 2021 Aug 2;11(8):e046701. doi: 10.1136/bmjopen-2020-046701. BMJ Open. 2021. PMID: 34341043 Free PMC article.
References
-
- Cutolo M, Brizzolara R, Atzeni F, et al. . The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci. 2010;1193:36–42. - PubMed
-
- Zen M, Ghirardello A, Iaccarino L, et al. . Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140(13-14):187–201. - PubMed
-
- Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005;11(4):411–423. - PubMed
-
- Ladikou EE, Kassi E. The emerging role of estrogen in B cell malignancies. Leuk Lymphoma. 2017;58(3):528–539. - PubMed